Why TelyRx Holdings Inc. stock is skyrocketing today

TelyRx Holdings Inc. has seen a remarkable surge in its stock price, gaining over 6% in just one day.

In the latest trading session, TelyRx Holdings Inc. (TELY.TO) closed up 6.22% at CA$2.56. This increase comes as the company reports rising revenues and more prescriptions filled, which could signal positive momentum for investors.

Investor takeaway: Investors should look at TelyRx's recent financial performance and growth in prescription fills as encouraging signs, though the company still faces challenges with net losses.

TelyRx's Stock Rises 6.22% in One Day

The stock's rise reflects growing investor confidence as TelyRx continues to expand its revenue and prescription metrics.

Revenue Growth Signals Potential

TelyRx reported a remarkable increase in revenue, reaching $19.4 million in Q1 2026, compared to just $6.9 million in the same quarter last year. This growth is largely due to an increase in the number of prescriptions filled, which rose to 236,000 from 82,000 a year prior. Such metrics indicate strong demand for TelyRx's offerings and could attract further investor interest.

Challenges Ahead Despite Growth

While the revenue figures are promising, TelyRx's net loss of $4.7 million in Q1 2026 raises questions about its profitability. Investors should remain cautious, as the company needs to address its financial health to sustain long-term growth. The current trajectory suggests potential, but the path to profitability remains uncertain.